Below are the most recent publications written about "Drug Resistance, Bacterial" by people in Profiles.
-
Xie M, Gao M, Yun Y, Malmsten M, Rotello VM, Zboril R, Akhavan O, Kraskouski A, Amalraj J, Cai X, Lu J, Zheng H, Li R. Antibacterial Nanomaterials: Mechanisms, Impacts on Antimicrobial Resistance and Design Principles. Angew Chem Int Ed Engl. 2023 04 17; 62(17):e202217345.
-
Rowlinson E, Soge OO, Hughes JP, Berzkalns A, Thibault C, Kerani RP, Khosropour CM, Manhart LE, Golden MR, Barbee LA. Prior Exposure to Azithromycin and Azithromycin Resistance Among Persons Diagnosed With Neisseria gonorrhoeae Infection at a Sexual Health Clinic: 2012-2019. Clin Infect Dis. 2023 02 08; 76(3):e1270-e1276.
-
Rothberg MB, Haessler S, Deshpande A, Yu PC, Lindenauer PK, Zilberberg MD, Higgins TL, Imrey PB. Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia. Infect Control Hosp Epidemiol. 2023 Jul; 44(7):1143-1150.
-
Li X, Le W, Lou X, Genco CA, Rice PA, Su X. In Vitro Activity of Ertapenem against Neisseria gonorrhoeae Clinical Isolates with Decreased Susceptibility or Resistance to Extended-Spectrum Cephalosporins in Nanjing, China (2013 to 2019). Antimicrob Agents Chemother. 2022 05 17; 66(5):e0010922.
-
Bettoni S, Maziarz K, Stone MRL, Blaskovich MAT, Potempa J, Bazzo ML, Unemo M, Ram S, Blom AM. Serum Complement Activation by C4BP-IgM Fusion Protein Can Restore Susceptibility to Antibiotics in Neisseria gonorrhoeae. Front Immunol. 2021; 12:726801.
-
Ben-Chetrit E, Mc Gann P, Maybank R, Stam J, Assous MV, Katz DE. Colistin-resistant?Klebsiella pneumoniae?bloodstream infection: old drug, bad bug. Arch Microbiol. 2021 Aug; 203(6):2999-3006.
-
Shamma F, Papavinasasundaram K, Quintanilla SY, Bandekar A, Sassetti C, Boutte CC. Phosphorylation on PstP Regulates Cell Wall Metabolism and Antibiotic Tolerance in Mycobacterium smegmatis. J Bacteriol. 2021 01 25; 203(4).
-
Rosener B, Sayin S, Oluoch PO, Garc?a Gonz?lez AP, Mori H, Walhout AJ, Mitchell A. Evolved bacterial resistance against fluoropyrimidines can lower chemotherapy impact in the Caenorhabditis elegans host. Elife. 2020 11 30; 9.
-
Makabenta JMV, Nabawy A, Li CH, Schmidt-Malan S, Patel R, Rotello VM. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nat Rev Microbiol. 2021 01; 19(1):23-36.
-
Syed MA, Ullah H, Tabassum S, Fatima B, Woodley TA, Ramadan H, Jackson CR. Staphylococci in poultry intestines: a comparison between farmed and household chickens. Poult Sci. 2020 Sep; 99(9):4549-4557.